3-[15-chloro-9-(cyclohexyloxymethyl)-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[15-chloro-9-(cyclopropyloxymethyl)-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-chloro-5-(pyridin-2-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-chloro-5-(pyridin-3-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole;5-[16-chloro-5-(pyridin-2-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-3-propan-2-yl-1,2,4-oxadiazole

C114H103Cl5N38O7 — CID 158731915

IUPAC3-[15-chloro-9-(cyclohexyloxymethyl)-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[15-chloro-9-(cyclopropyloxymethyl)-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-chloro-5-(pyridin-2-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-chloro-5-(pyridin-3-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole;5-[16-chloro-5-(pyridin-2-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-3-propan-2-yl-1,2,4-oxadiazole
SMILESCC(C)c1nc(-c2ncn3c2Cc2c(Cc4ccccn4)nnn2-c2cc(Cl)ccc2-3)no1.CC(C)c1nc(-c2ncn3c2Cc2c(Cc4cccnc4)nnn2-c2cc(Cl)ccc2-3)no1.CC(C)c1nc(-c2ncn3c2Cn2c(COC4CC4)nnc2-c2cc(Cl)ccc2-3)no1.CC(C)c1nc(-c2ncn3c2Cn2c(COC4CCCCC4)nnc2-c2cc(Cl)ccc2-3)no1.CC(C)c1noc(-c2ncn3c2Cc2c(Cc4ccccn4)nnn2-c2cc(Cl)ccc2-3)n1
InChIInChI=1S/C24H26ClN7O2.3C23H19ClN8O.C21H20ClN7O2/c1-14(2)24-27-22(30-34-24)21-19-11-31-20(12-33-16-6-4-3-5-7-16)28-29-23(31)17-10-15(25)8-9-18(17)32(19)13-26-21;1-13(2)23-27-22(29-33-23)21-20-10-18-16(8-14-4-3-7-25-11-14)28-30-32(18)19-9-15(24)5-6-17(19)31(20)12-26-21;1-13(2)23-27-22(29-33-23)21-20-11-18-16(10-15-5-3-4-8-25-15)28-30-32(18)19-9-14(24)6-7-17(19)31(20)12-26-21;1-13(2)22-27-23(33-29-22)21-20-11-18-16(10-15-5-3-4-8-25-15)28-30-32(18)19-9-14(24)6-7-17(19)31(20)12-26-21;1-11(2)21-24-19(27-31-21)18-16-8-28-17(9-30-13-4-5-13)25-26-20(28)14-7-12(22)3-6-15(14)29(16)10-23-18/h8-10,13-14,16H,3-7,11-12H2,1-2H3;3-7,9,11-13H,8,10H2,1-2H3;2*3-9,12-13H,10-11H2,1-2H3;3,6-7,10-11,13H,4-5,8-9H2,1-2H3
InChIKeyILEWGNHOBTVPTH-UHFFFAOYSA-N
MW2294.60 g/mol
LogP21.68
Rot. Bonds22

About 3-[15-chloro-9-(cyclohexyloxymethyl)-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[15-chloro-9-(cyclopropyloxymethyl)-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-chloro-5-(pyridin-2-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-chloro-5-(pyridin-3-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole;5-[16-chloro-5-(pyridin-2-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-3-propan-2-yl-1,2,4-oxadiazole

3-[15-chloro-9-(cyclohexyloxymethyl)-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[15-chloro-9-(cyclopropyloxymethyl)-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-chloro-5-(pyridin-2-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-chloro-5-(pyridin-3-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole;5-[16-chloro-5-(pyridin-2-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-3-propan-2-yl-1,2,4-oxadiazole (PubChem CID 158731915) has the molecular formula C114H103Cl5N38O7 and a molecular weight of 2294.60 g/mol. Its IUPAC name is 3-[15-chloro-9-(cyclohexyloxymethyl)-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[15-chloro-9-(cyclopropyloxymethyl)-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-chloro-5-(pyridin-2-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-chloro-5-(pyridin-3-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole;5-[16-chloro-5-(pyridin-2-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-3-propan-2-yl-1,2,4-oxadiazole.

Molecular Properties

Compound Name3-[15-chloro-9-(cyclohexyloxymethyl)-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[15-chloro-9-(cyclopropyloxymethyl)-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-chloro-5-(pyridin-2-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-chloro-5-(pyridin-3-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole;5-[16-chloro-5-(pyridin-2-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-3-propan-2-yl-1,2,4-oxadiazole
PubChem CID158731915
Molecular FormulaC114H103Cl5N38O7
Molecular Weight2294.60 g/mol
Exact Mass2290.73
IUPAC Name3-[15-chloro-9-(cyclohexyloxymethyl)-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[15-chloro-9-(cyclopropyloxymethyl)-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-chloro-5-(pyridin-2-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-chloro-5-(pyridin-3-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole;5-[16-chloro-5-(pyridin-2-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-3-propan-2-yl-1,2,4-oxadiazole
SMILESCC(C)c1nc(-c2ncn3c2Cc2c(Cc4ccccn4)nnn2-c2cc(Cl)ccc2-3)no1.CC(C)c1nc(-c2ncn3c2Cc2c(Cc4cccnc4)nnn2-c2cc(Cl)ccc2-3)no1.CC(C)c1nc(-c2ncn3c2Cn2c(COC4CC4)nnc2-c2cc(Cl)ccc2-3)no1.CC(C)c1nc(-c2ncn3c2Cn2c(COC4CCCCC4)nnc2-c2cc(Cl)ccc2-3)no1.CC(C)c1noc(-c2ncn3c2Cc2c(Cc4ccccn4)nnn2-c2cc(Cl)ccc2-3)n1
InChIInChI=1S/C24H26ClN7O2.3C23H19ClN8O.C21H20ClN7O2/c1-14(2)24-27-22(30-34-24)21-19-11-31-20(12-33-16-6-4-3-5-7-16)28-29-23(31)17-10-15(25)8-9-18(17)32(19)13-26-21;1-13(2)23-27-22(29-33-23)21-20-10-18-16(8-14-4-3-7-25-11-14)28-30-32(18)19-9-15(24)5-6-17(19)31(20)12-26-21;1-13(2)23-27-22(29-33-23)21-20-11-18-16(10-15-5-3-4-8-25-15)28-30-32(18)19-9-14(24)6-7-17(19)31(20)12-26-21;1-13(2)22-27-23(33-29-22)21-20-11-18-16(10-15-5-3-4-8-25-15)28-30-32(18)19-9-14(24)6-7-17(19)31(20)12-26-21;1-11(2)21-24-19(27-31-21)18-16-8-28-17(9-30-13-4-5-13)25-26-20(28)14-7-12(22)3-6-15(14)29(16)10-23-18/h8-10,13-14,16H,3-7,11-12H2,1-2H3;3-7,9,11-13H,8,10H2,1-2H3;2*3-9,12-13H,10-11H2,1-2H3;3,6-7,10-11,13H,4-5,8-9H2,1-2H3
InChIKeyILEWGNHOBTVPTH-UHFFFAOYSA-N
XLogP21.68
TPSA494.38 Ų
H-Bond Donors
H-Bond Acceptors45
Rotatable Bonds22
Heavy Atoms164
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002294.60
LogP ≤ 521.68
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1045

Analyze 3-[15-chloro-9-(cyclohexyloxymethyl)-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[15-chloro-9-(cyclopropyloxymethyl)-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-chloro-5-(pyridin-2-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-chloro-5-(pyridin-3-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole;5-[16-chloro-5-(pyridin-2-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-3-propan-2-yl-1,2,4-oxadiazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-[15-chloro-9-(cyclohexyloxymethyl)-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[15-chloro-9-(cyclopropyloxymethyl)-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-chloro-5-(pyridin-2-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-chloro-5-(pyridin-3-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole;5-[16-chloro-5-(pyridin-2-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-3-propan-2-yl-1,2,4-oxadiazole?
The IUPAC name of 3-[15-chloro-9-(cyclohexyloxymethyl)-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[15-chloro-9-(cyclopropyloxymethyl)-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-chloro-5-(pyridin-2-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-chloro-5-(pyridin-3-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole;5-[16-chloro-5-(pyridin-2-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-3-propan-2-yl-1,2,4-oxadiazole (CID 158731915) is 3-[15-chloro-9-(cyclohexyloxymethyl)-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[15-chloro-9-(cyclopropyloxymethyl)-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-chloro-5-(pyridin-2-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-chloro-5-(pyridin-3-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole;5-[16-chloro-5-(pyridin-2-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-3-propan-2-yl-1,2,4-oxadiazole.
What is the SMILES notation for 3-[15-chloro-9-(cyclohexyloxymethyl)-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[15-chloro-9-(cyclopropyloxymethyl)-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-chloro-5-(pyridin-2-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-chloro-5-(pyridin-3-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole;5-[16-chloro-5-(pyridin-2-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-3-propan-2-yl-1,2,4-oxadiazole?
The canonical SMILES for 3-[15-chloro-9-(cyclohexyloxymethyl)-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[15-chloro-9-(cyclopropyloxymethyl)-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-chloro-5-(pyridin-2-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-chloro-5-(pyridin-3-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole;5-[16-chloro-5-(pyridin-2-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-3-propan-2-yl-1,2,4-oxadiazole is CC(C)c1nc(-c2ncn3c2Cc2c(Cc4ccccn4)nnn2-c2cc(Cl)ccc2-3)no1.CC(C)c1nc(-c2ncn3c2Cc2c(Cc4cccnc4)nnn2-c2cc(Cl)ccc2-3)no1.CC(C)c1nc(-c2ncn3c2Cn2c(COC4CC4)nnc2-c2cc(Cl)ccc2-3)no1.CC(C)c1nc(-c2ncn3c2Cn2c(COC4CCCCC4)nnc2-c2cc(Cl)ccc2-3)no1.CC(C)c1noc(-c2ncn3c2Cc2c(Cc4ccccn4)nnn2-c2cc(Cl)ccc2-3)n1.
What is the InChIKey of 3-[15-chloro-9-(cyclohexyloxymethyl)-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[15-chloro-9-(cyclopropyloxymethyl)-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-chloro-5-(pyridin-2-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-chloro-5-(pyridin-3-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole;5-[16-chloro-5-(pyridin-2-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-3-propan-2-yl-1,2,4-oxadiazole?
The InChIKey is ILEWGNHOBTVPTH-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H26ClN7O2.3C23H19ClN8O.C21H20ClN7O2/c1-14(2)24-27-22(30-34-24)21-19-11-31-20(12-33-16-6-4-3-5-7-16)28-29-23(31)17-10-15(25)8-9-18(17)32(19)13-26-21;1-13(2)23-27-22(29-33-23)21-20-10-18-16(8-14-4-3-7-25-11-14)28-30-32(18)19-9-15(24)5-6-17(19)31(20)12-26-21;1-13(2)23-27-22(29-33-23)21-20-11-18-16(10-15-5-3-4-8-25-15)28-30-32(18)19-9-14(24)6-7-17(19)31(20)12-26-21;1-13(2)22-27-23(33-29-22)21-20-11-18-16(10-15-5-3-4-8-25-15)28-30-32(18)19-9-14(24)6-7-17(19)31(20)12-26-21;1-11(2)21-24-19(27-31-21)18-16-8-28-17(9-30-13-4-5-13)25-26-20(28)14-7-12(22)3-6-15(14)29(16)10-23-18/h8-10,13-14,16H,3-7,11-12H2,1-2H3;3-7,9,11-13H,8,10H2,1-2H3;2*3-9,12-13H,10-11H2,1-2H3;3,6-7,10-11,13H,4-5,8-9H2,1-2H3.
What are the key properties of 3-[15-chloro-9-(cyclohexyloxymethyl)-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[15-chloro-9-(cyclopropyloxymethyl)-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-chloro-5-(pyridin-2-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-chloro-5-(pyridin-3-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole;5-[16-chloro-5-(pyridin-2-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-3-propan-2-yl-1,2,4-oxadiazole?
3-[15-chloro-9-(cyclohexyloxymethyl)-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[15-chloro-9-(cyclopropyloxymethyl)-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-chloro-5-(pyridin-2-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-chloro-5-(pyridin-3-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole;5-[16-chloro-5-(pyridin-2-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-3-propan-2-yl-1,2,4-oxadiazole has a molecular weight of 2294.60 g/mol, XLogP of 21.68, 22 rotatable bonds, 0 hydrogen bond donors, and 45 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[15-chloro-9-(cyclohexyloxymethyl)-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[15-chloro-9-(cyclopropyloxymethyl)-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-chloro-5-(pyridin-2-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-chloro-5-(pyridin-3-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole;5-[16-chloro-5-(pyridin-2-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-3-propan-2-yl-1,2,4-oxadiazole is sourced from PubChem (CID 158731915), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).